Article Details

Aurinia Pharmaceuticals (NASDAQ:AUPH) Upgraded to "Hold" at Zacks Investment Research

Retrieved on: 2021-01-01 08:17:37

Tags for this article:

Click the tags to see associated articles and topics

Aurinia Pharmaceuticals (NASDAQ:AUPH) Upgraded to "Hold" at Zacks Investment Research. View article details on hiswai:

Excerpt

Man Group plc now owns 315,331 shares of the biotechnology company's stock worth $5,124,000 after acquiring an additional 231,743 shares in the ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up